Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
United Therapeutics Corp
Nieuws
United Therapeutics Corp
UTHR
NAS
: UTHR
| ISIN: US91307C1027
14/11/2024
386,27 USD
(-3,54%)
(-3,54%)
14/11/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
3 november 2021 ·
United Therapeutics Corporation Reports Third Quarter 2021 Financial Results
· Persbericht
1 november 2021 ·
United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference
· Persbericht
27 oktober 2021 ·
United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021
· Persbericht
21 oktober 2021 ·
United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021
· Persbericht
18 oktober 2021 ·
United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application
· Persbericht
11 oktober 2021 ·
United Therapeutics to Present New Data at CHEST Annual Meeting 2021
· Persbericht
30 september 2021 ·
United Therapeutics Converts to a Public Benefit Corporation Following Shareholder Approval
· Persbericht
10 september 2021 ·
United Therapeutics Releases its Annual Corporate Responsibility Report
· Persbericht
7 september 2021 ·
United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021
· Persbericht
25 augustus 2021 ·
United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month
· Persbericht
24 augustus 2021 ·
United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021
· Persbericht
4 augustus 2021 ·
United Therapeutics Corporation Reports Second Quarter 2021 Financial Results
· Persbericht
3 augustus 2021 ·
United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference
· Persbericht
28 juli 2021 ·
United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021
· Persbericht
30 juni 2021 ·
United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study
· Persbericht
16 juni 2021 ·
MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA
· Persbericht
16 juni 2021 ·
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review
· Persbericht
7 juni 2021 ·
United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia
· Persbericht
3 juni 2021 ·
United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis
· Persbericht
25 mei 2021 ·
United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe